Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 86688 refers to the laboratory test for antibodies to human T-lymphotropic virus type II (HTLV-II). This test is part of a broader category that includes testing for antibodies to human T-lymphotropic virus type I (HTLV-I) and human immunodeficiency virus (HIV). HTLV-I and HTLV-II are retroviruses that can lead to serious health conditions, including disorders affecting bone marrow and blood cells, with HTLV-I being associated with adult T-cell leukemia. The transmission of these viruses can occur through sexual contact, unscreened blood transfusions, sharing of needles, and from mother to child during pregnancy or breastfeeding. The testing process typically involves an enzyme immunosorbent assay (EIA), which is designed to detect the presence of antibodies in human serum or plasma. If the initial EIA test yields a positive result, a confirmatory test is conducted using methods such as immunoblot or Western blot, which are essential for accurately identifying the presence of these viruses. The Western blot technique involves separating proteins by size and shape through gel electrophoresis, followed by the application of patient samples to detect specific antibodies. This comprehensive testing approach is crucial for diagnosing infections that can severely compromise the immune system, particularly in the case of HIV, which can progress to acquired immunodeficiency syndrome (AIDS).
© Copyright 2026 Coding Ahead. All rights reserved.
The antibody test for HTLV-II (CPT® Code 86688) is indicated for the detection of antibodies in individuals who may have been exposed to the human T-lymphotropic virus type II. The following conditions and situations warrant this testing:
The procedure for testing antibodies to HTLV-II involves several key steps, which are outlined below:
After the antibody testing for HTLV-II is completed, the patient may receive their results within a specified timeframe, depending on the laboratory's processing capabilities. If the EIA test is positive, the patient will be informed about the need for confirmatory testing and the implications of the results. It is essential for healthcare providers to discuss the results with the patient, including potential follow-up care, further testing, and counseling regarding the implications of a positive result, especially in relation to transmission risks and management of any associated health conditions. Patients may also be advised on preventive measures to avoid further transmission of the virus.
| Short Descr | HTLV-II ANTIBODY | Medium Descr | ANTIBODY HTLV-II | Long Descr | Antibody; HTLV-II | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 235 - Other Laboratory |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 1993-01-01 | Added | First appearance in code book in 1993. |
Get instant expert-level medical coding assistance.